-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Final rule; technical amendment.
SUMMARY:
The Food and Drug Administration (FDA) is amending its regulations to update the address for submitting bar code exemption requests to the Center for Drug Evaluation and Research (CDER). This action is being taken to ensure accuracy and clarity in the Agency's regulations.
DATES:
This rule is effective March 9, 2011.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Rikin Mehta, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, Rm. 5235, Silver Spring, MD 20993-0002, 301-796-3937.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
FDA is amending 21 CFR 201.25(d)(2) to update the address for submitting bar code exemption requests to CDER. The new address for these submissions is Office of Compliance, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, Silver Spring, MD 20993-0002. This action is being taken to ensure accuracy and clarity in the Agency's regulations.
Publication of this document constitutes final action on these changes under the Administrative Procedure Act (5 U.S.C. 553). FDA has determined that notice and public comment are unnecessary because this amendment to the regulations provides only technical changes to update an address for submitting bar code exemption requests to CDER.
Start List of SubjectsList of Subjects in 21 CFR Part 201
- Drugs
- Labeling
- Reporting and recordkeeping requirements
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, 21 CFR part 201 is amended as follows:
Start PartPART 201—LABELING
End Part Start Amendment Part1. The authority citation for 21 CFR part 201 continues to read as follows:
End Amendment Part Start Amendment Part2. Section 201.25 is amended by revising paragraph (d)(2) to read as follows:
End Amendment PartBar code label requirements.* * * * *(d) * * *
(2) Requests for an exemption should be sent to the Office of Compliance, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, Silver Spring, MD 20993-0002 (requests involving a drug product) or to the Office of Compliance and Biologics Quality (HFM-600), Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852 (requests involving a biological product).
Dated: March 3, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-5288 Filed 3-8-11; 8:45 am]
BILLING CODE 4160-01-P
Document Information
- Effective Date:
- 3/9/2011
- Published:
- 03/09/2011
- Department:
- Food and Drug Administration
- Entry Type:
- Rule
- Action:
- Final rule; technical amendment.
- Document Number:
- 2011-5288
- Dates:
- This rule is effective March 9, 2011.
- Pages:
- 12847-12847 (1 pages)
- Docket Numbers:
- Docket No. FDA-2011-N-0101
- Topics:
- Drugs, Labeling, Reporting and recordkeeping requirements
- PDF File:
- 2011-5288.pdf
- CFR: (1)
- 21 CFR 201.25